In 2025, medical device manufacturers are grappling with heightened regulatory uncertainty, leading to slower reviews and communication difficulties with the FDA. This situation drives them to reassess operations for compliance and risk management, with a strong emphasis on maintaining product quality, which is vital for patient safety.
Why it Pays to Prioritize Quality Amid Regulatory Uncertainty
Related Posts
UiPath Test Manager: Aligning Business Intent with Automated Execution
UiPath Test Manager helps enterprises align automated execution with business intent by connecting requirements, test cases, execution results,…
Creaform CUBE-R M Series
Creaform, a business of AMETEK, Inc. and worldwide provider of automated and portable 3D measurement solutions, announced the…
Coesia Acquires Autoware
Coesia, a global leader in advanced industrial and packaging solutions, has announced the acquisition of the majority capital…